What is the starting dosage of ziprasidone (Geodon) for an adult patient with schizophrenia or bipolar disorder and no significant medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dosage of Ziprasidone

For schizophrenia, start ziprasidone at 40 mg twice daily (80 mg/day total) on Day 1, then increase to 80 mg twice daily (160 mg/day total) on Day 2, with all doses taken with food containing at least 500 kcal. 1, 2

Oral Dosing for Schizophrenia

  • Initial dose: 40 mg twice daily (80 mg/day) on the first day of treatment 1
  • Target dose: Increase to 80 mg twice daily (160 mg/day) by Day 2, as only doses of 120-160 mg/day have demonstrated superiority over placebo in clinical trials 1, 3
  • Maximum FDA-approved dose: 160 mg/day (80 mg twice daily) 1

Critical Administration Requirement

  • All doses must be taken with food containing ≥500 kcal to achieve adequate bioavailability (~60% with food vs. significantly lower without) 1, 2
  • This food requirement is non-negotiable for therapeutic efficacy 2

Oral Dosing for Bipolar I Disorder (Acute Manic/Mixed Episodes)

  • Day 1: 40 mg twice daily (80 mg/day) 4, 1
  • Day 2 onward: Titrate rapidly to 80 mg twice daily (160 mg/day) 4, 2
  • Typical therapeutic range: 40-80 mg twice daily (80-160 mg/day total), with mean effective doses in clinical trials of 112-132 mg/day 1
  • Rapid titration to 120-160 mg/day is necessary for optimal efficacy in acute mania 2

Intramuscular Dosing for Acute Agitation

  • Initial IM dose: 10-20 mg, with 20 mg demonstrating more significant reduction in agitation scores 5
  • Repeat dosing: Can be repeated every 2-4 hours as needed 5
  • Maximum daily IM dose: 40 mg/day 4, 5
  • Onset of action: 15-30 minutes after injection 5

Common Pitfalls to Avoid

  • Do not start at doses below 40 mg twice daily for schizophrenia, as trials using 20 mg twice daily failed to show superiority over placebo 1
  • Do not administer without adequate food, as this dramatically reduces bioavailability and therapeutic effect 2
  • Do not use in patients with recent MI, baseline QT prolongation, or those taking other QT-prolonging medications due to risk of QTc prolongation 4, 5
  • Obtain baseline ECG before initiating treatment to screen for QTc prolongation 4

Adjunctive Medications During Titration

  • Temporary short-term benzodiazepines (lorazepam for agitation or temazepam for insomnia) may be used during the initial titration period, as was done in clinical trials 2

Metabolic Advantages

  • Ziprasidone is one of the most weight-neutral antipsychotics with minimal impact on cholesterol, triglycerides, or glycemic control, making it particularly suitable for patients with metabolic concerns 4, 5

References

Research

Ziprasidone: the fifth atypical antipsychotic.

The Annals of pharmacotherapy, 2002

Guideline

Ziprasidone Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ziprasidone Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the dosage and usage of ziprasidone (Geodon) for treating schizophrenia and bipolar disorder?
What is the maximum dosage of Geodon (ziprasidone) that can be administered within a 6-hour window?
What is the appropriate dosage and monitoring for Geodon (ziprasidone) 40 mg twice daily (bid) in an inpatient setting for acute schizophrenia or bipolar disorder?
What is the recommended dosing and monitoring for Geodon (ziprasidone) as adjunct therapy for aggressive behavior in a patient with a history of cardiovascular disease?
What is the brand name for Ziprasidone (atypical antipsychotic)?
What is the recommended treatment for a patient with post-traumatic stress disorder (PTSD)?
What are the current Centers for Disease Control and Prevention (CDC) guidelines for isolation after influenza and Coronavirus Disease 2019 (COVID-19) for the general population?
How to manage hyperkalemia in a patient taking carvedilol (beta-blocker), dapagliflozin (SGLT2 inhibitor), furosemide (loop diuretic), and nifedipine ER (calcium channel blocker)?
What does the chest x-ray show in a patient with a 5-day small bowel obstruction who undergoes surgery and experiences massive regurgitation during rapid sequence induction (RSI) of anesthesia?
What is the best course of treatment for acne in adolescents or young adults?
Could a 4-year-old patient with progressive facial asymmetry and unilateral enhancement of the labyrinthine segment on Magnetic Resonance Imaging (MRI) be related to their relative who developed left-sided weakness in focal areas?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.